-
Listing
-
Trading
Where European Government Bonds meet the futureFixed Income derivativesLer maisTrade Mini Bond Futures on main European Government Bonds
-
Clearing
Step into Europe’s next phase of Repo ClearingRepo ClearingLer maisEuronext is expanding its repo clearing services to boost market access, liquidity provision and collateral optimisation across Europe.
-
CSD
European CSD modelBuilding the CSD of Choice in EuropeLer maisEuronext Securities is shaping the future of European capital markets by enhancing integration, connectivity, and innovation.
-
Technology
Euronext Technology SolutionsHigh-Frequency Trading Solution (HFTS)Ler maisThe new generation of high-frequency risk trading platforms, offering the highest performance with ultra-low latency and minimal jitter, all at a low total cost of ownership.
-
Data
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesLer maisThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
About Euronext
Euronext strategic planInnovate for Growth 2027Ler maisShaping capital markets for future generations
Forbion
15/10/2018
Forbion celebrates success fourth closed end fund by sounding the gong
Sander Slootweg, Managing Partner at Forbion, one of the high profile VC investment firms in Europe, opens trading..
Forbion recently announced the final close of its new flagship fund, Forbion IV. The fund closed above its original target at EUR 360 million and was significantly oversubscribed. With this new fund under its belt, Forbion intends to build and invest in around 15 companies, which develop new medicines for high and unmet medical needs, impacting patients’ lives. These development-stage companies will be either acquired by strategic buyers like major pharma or biotech companies or will be listed on an exchange.
For more Information: www.forbion.com